Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...

"The EDSS has a number of limitations and may also measure changes that are not related to MS, such as older age and multiple ...

Columnist Ben Hofmeister explains a handy acronym that's helped him and can help you motivate yourself with MS.

UCSF study calls attention to the potential for estrogen therapy in slowing the course of the disease.A new study by UC San Francisco has found that ...

Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...

Corvette ZR1 with the ZTK Performance Package and $25,000 cash by supporting MS Solutions and their work for MS patients.

Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...

"I tell my right foot to go somewhere, and it wants to go somewhere else. I gotta be very precise about, moving around, ...

Cohen also twice survived colon cancer, a blood clot in his lung and, in his later years, was left legally legally blind by the MS, according to People.